ReviewJPRAS open2026
Cannula is safer than needle in filler injection?
Review in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Operational Standard for Tissue-Extracted Collagen Facial Injection Techniques.Clinical, cosmetic and investigational dermatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The choice between cannulas and needles for dermal filler injection has direct implications for safety, efficacy, and patient experience. This narrative review synthesizes evidence from randomized controlled trials, observational studies, cadaveric/anatomical work, and expert consensus to compare complication profiles and practical use-cases. Across multiple studies, cannulas-by virtue of their blunt tips and gliding technique-are associated with lower rates of bruising and a reduced signal for vascular occlusion in high-risk, vessel-dense regions, while also improving patient comfort and downtime. However, cannulas are not inherently risk-free: arterial wall penetration and ischemic events remain possible with improper plane selection, excessive injection pressure, or inadequate anatomical control. Needles retain advantages for precise, focal periosteal or ligamentous support and for select micro-bolus indications. Publication bias and heterogeneous endpoints likely underestimate true complication rates for both devices. Guided by anatomy and procedural goals, a tailored approach is recommended: preferential cannula use for broad, low-pressure distribution in vessel-dense areas; needle use for targeted structural points with strict low-volume, low-pressure technique. Ultrasound guidance further enhances plane confirmation and vascular avoidance. We conclude that device selection should be individualized to region, indication, and operator skill, coupled with slow injection, minimal aliquots, and ongoing training to optimize patient safety and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.